Literature DB >> 17916324

Ontogeny up-regulates renal Na(+)/Cl(-)/creatine transporter in rat.

M García-Delgado1, P García-Miranda, M J Peral, M L Calonge, A A Ilundáin.   

Abstract

Creatine plays a role in energy storage and transport/shuttle of high-energy phosphate in heart, brain, retina, testis and skeletal muscle. These tissues take creatine from the plasma via a 2Na(+)/1Cl(-)/1creatine cotransporter (CRT). We have previously demonstrated that renal apical membrane presents a 2Na(+)/1Cl(-)/1creatine cotransport activity. The goal of this study was to determine whether this transporter is ontogenically regulated. Na(+)/Cl(-)/creatine transport activity was evaluated by measuring [(14)C]-creatine uptake into renal brush-border membrane vesicles. CRT mRNA expression was measured by Northern and real-time PCR assays. E20 foetuses, newborn, suckling, weaning and adult (2- and 8-month-old) Wistar rats were used. The results revealed that neither the vesicular volume, the binding of creatine to the brush-border membrane vesicles, nor the purity of the brush-border membrane vesicle preparations was affected by maturation. Fetal and neonatal kidneys contained a creatine transporter that was qualitatively indistinguishable from that in the adult: it was concentrative, Na(+)- and Cl(-)-dependent, electrogenic and inhibited by guanidinopropionic acid. Maturation increased this transport activity by increasing the maximal rate of transport (V(max)) without significantly changing the apparent K(m). Northern analysis revealed two transcripts for CRT of 2.7 kb and 4.2 kb in all the ages tested. Northern and real-time PCR assays showed that, as seen with NaCl-dependent creatine transport activity, maturation increased CRT mRNA expression. This study reports for the first time that: (i) an apical renal Na(+)/Cl(-)/creatine cotransporter is already active in rat foetuses and (ii) development regulates Na(+)/Cl(-)/creatine cotransport activity by increasing the density and/or turnover of the transporters.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916324     DOI: 10.1016/j.bbamem.2007.07.022

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Lack of reelin modifies the gene expression in the small intestine of mice.

Authors:  P García-Miranda; M D Vázquez-Carretero; G Gutiérrez; M J Peral; A A Ilundáin
Journal:  J Physiol Biochem       Date:  2011-12-08       Impact factor: 4.158

2.  Ontogeny of D-mannose transport and metabolism in rat small intestine.

Authors:  Mecedes Cano; Anunciación A Ilundain
Journal:  J Membr Biol       Date:  2010-06-04       Impact factor: 1.843

Review 3.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

4.  Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells.

Authors:  Hui Li; Ramon F Thali; Christy Smolak; Fan Gong; Rodrigo Alzamora; Theo Wallimann; Roland Scholz; Núria M Pastor-Soler; Dietbert Neumann; Kenneth R Hallows
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

5.  Changes in creatine transporter function during cardiac maturation in the rat.

Authors:  Alexandra Fischer; Michiel Ten Hove; Liam Sebag-Montefiore; Helga Wagner; Kieran Clarke; Hugh Watkins; Craig A Lygate; Stefan Neubauer
Journal:  BMC Dev Biol       Date:  2010-06-22       Impact factor: 1.978

6.  Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse.

Authors:  Zoe Ireland; Aaron P Russell; Theo Wallimann; David W Walker; Rod Snow
Journal:  BMC Dev Biol       Date:  2009-07-01       Impact factor: 1.978

Review 7.  The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic review.

Authors:  Inge Oudman; Joseph F Clark; Lizzy M Brewster
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.